Dr. Ozambela Performs First U.S. AI-Integrated HIFU Procedure Utilizing PSMA-Guided Technology
Dr. Manuel Ozambela performed the first U.S. HIFU procedure integrating AI with PSMA-guided imaging at Baptist Health South Florida — advancing precision, focal prostate cancer treatment.
In a groundbreaking advancement for focal therapy and precision prostate cancer treatment, Dr Manuel Ozambela performed the first High-Intensity Focused Ultrasound (HIFU) procedure in the United States integrating artificial intelligence with PSMA-guided imaging. The procedure was performed at Baptist Health South Florida.
The novel approach combines AI-assisted treatment planning with molecular imaging to improve cancer localization and treatment precision. Emerging interest in focal therapies such as HIFU and NanoKnife reflects a growing emphasis on preserving quality of life while effectively treating localized prostate cancer. Community discussions among prostate cancer patients frequently highlight the appeal of focal therapy for carefully selected candidates because of its potential to minimize treatment-related side effects while maintaining future treatment options.
This milestone further positions South Florida as an important center for innovation in focal therapy, precision imaging, and minimally invasive prostate cancer treatment.
